Study of Tislelizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer

Peking University Third Hospital, Beijing

Cancer Hospital Chinese Academy of Medical Sciences, Beijing

Peking University First Hospital, Beijing

Peking Union Medical College Hospital, Beijing

The First Hospital of China Medical University, Shenyang

Liaoning Cancer Hospital and Institute, Shenyang

The Second Hospital of Dalian Medical University, Dalian

Fudan University Shanghai Cancer Center, Shanghai

Affiliated Zhongshan Hospital of Fudan University, Shanghai

Huadong Hospital Affiliated to Fudan University, Shanghai

Jiangsu Province Cancer Hospital, Nanjing

Anhui Provincial Hospital, Hefei

The Second Affiliated Hospital of Tianjin Medical University, Tianjin

Zhejiang Provincial Peoples Hospital, Hangzhou

Zhejiang Cancer Hospital, Hangzhou

The First Provincial Wenzhou Hospital of Zhejiang, Wenzhou

The First Affiliated Hospital of Nanchang University Branch Donghu, Nanchang

Jiangxi Province Cancer Hospital, Nanchang

Fujian Medical University Union Hospital, Fuzhou

The First Affiliated Hospital of Xiamen University, Xiamen

Xiangya Hospital of Central South University, Changsha

Tongji Hospital of Tongji Medical College Huazhong University of Science and Technology, Wuhan

Sun Yat Sen Memorial Hospital, Sun Yat Sen University (North), Guangzhou

West China Hospital, Sichuan University, Chengdu

Seoul National University Hospital, Seoul

Gangnam Severance Hospital, Yonsei University Health System, Seoul

Samsung Medical Center, Seoul